Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Yaseen M Arabi1,2,3, Ayed Asseri4, Steve Webb5

  • 1Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

Insights

The global research response to coronavirus disease 2019 (COVID-19) has been rapid, with numerous studies and clinical trials initiated to understand and treat the novel virus. This swift action aims to accelerate the development of effective therapeutic options.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Clinical Research

Background:

  • The emergence of coronavirus disease 2019 (COVID-19) in late 2019 has led to a global health crisis.
  • As of March 18, 2020, over 204,610 cases were reported worldwide.
  • The rapid spread necessitated an urgent and comprehensive research response.

Purpose of the Study:

  • To characterize the novel coronavirus disease (COVID-19).
  • To evaluate potential therapeutic interventions for COVID-19.
  • To document the global research and clinical trial landscape for COVID-19.

Main Methods:

  • Systematic review of registered clinical trials.
  • Analysis of global case reporting data.
  • Literature search for ongoing research efforts.

Main Results:

  • Over 382 studies addressing COVID-19 were registered in clinical trial databases by March 12, 2020.
  • More than 80 of these registered studies were randomized controlled trials.
  • Significant global research activity is focused on understanding and treating COVID-19.

Conclusions:

  • The scientific community has mobilized rapidly to address the COVID-19 pandemic.
  • A substantial number of clinical trials are underway to find effective treatments.
  • Ongoing research is crucial for managing the current outbreak and future preparedness.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
321
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.6K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
81